Teresa Beninato

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy

Giovanni Fucà, Teresa Beninato, Marta Bini et al. · Targeted Oncology · 2021 · 58 citations

Inflammation, Pan-immune-inflammation Value, Cancer Immunosurveillance +11

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy

Arsela Prelaj, Mattia Boeri, Alessandro Robuschi et al. · Cancers · 2022 · 31 citations · Full text

Artificial Intelligence, Engineering, Machine Learning +23

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients

Arsela Prelaj, Edoardo Gregorio Galli, V. Miskovic et al. · Frontiers in Oncology · 2023 · 30 citations · Full text

STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines

Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo et al. · Journal of Thoracic Oncology · 2023 · 25 citations · Full text

Medicine, Thyroid Disease, Type B3 Thymoma +8

Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology

Sara Manglaviti, Marta Brambilla, Diego Signorelli et al. · Clinical Lung Cancer · 2021 · 17 citations

Uncommon Histology, Cancer Immunosurveillance, Immune-checkpoint Inhibitors +9